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Abstract
Background: Exosomes, derived from endocytic membrane vesicles are thought to participate in cell-cell communication
and protein and RNA delivery. They are ubiquitous in most body fluids (breast milk, saliva, blood, urine, malignant ascites,
amniotic, bronchoalveolar lavage, and synovial fluids). In particular, exosomes secreted in human saliva contain proteins and
nucleic acids that could be exploited for diagnostic purposes. To investigate this potential use, we isolated exosomes from
human saliva and characterized their structural and transcriptome contents.
Methodology: Exosomes were purified by differential ultracentrifugation and identified by immunoelectron microscopy
(EM), flow cytometry, and Western blot with CD63 and Alix antibodies. We then described the morphology, shape, size
distribution, and density using atomic force microscopy (AFM). Microarray analysis revealed that 509 mRNA core transcripts
are relatively stable and present in the exosomes. Exosomal mRNA stability was determined by detergent lysis with RNase A
treatment. In vitro, fluorescently labeled saliva exosomes could communicate with human keratinocytes, transferring their
genetic information to human oral keratinocytes to alter gene expression at a new location.
Conclusion: Our findings are consistent with the hypothesis that exosomes shuttle RNA between cells and that the RNAs
present in the exosomes may be a possible resource for disease diagnostics.
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Introduction
Exosomes-small nanovesicles released from various cells have
increasingly studied for their potential use in therapeutics and
diagnostics [1,2]. Exosomes are derived from endosomal mem-
brane compartments after fusion with the plasma membrane and
are released from activated cell surfaces [3,4,5]. These exosomes,
or microvesicular bodies (MVBs), are produced by different cell
types, including dendritic cells [6], macrophages [7], and
lymphocytes [8], as well as salivary gland epithelial cells [9] and
tumor cells [10]. Exosomes have been found in physiological fluids
such as saliva [11,12], plasma [2], urine [13], amniotic fluid [14],
malignant ascites [15], bronchoalveolar lavage fluid [16], synovial
fluids [17], and breast milk [18]. Although exosomes have been
identified in human saliva, their biochemical and biophysical
characteristics are largely unknown. Due to their small size,
morphological analysis of purity and exosome characterization has
solely been limited to electron microscopy (EM). Here, we
employed atomic force microscopy (AFM) to more thoroughly
characterize native exosomes without the need for fixation,
staining, or labeling of these particles. AFM has previously been
used to yield nanometer-scale topographical images of biological
molecules [19]. Using AFM, we showed a 3D structure of
exosomes from human saliva. To the best of our knowledge, such a
structure has not been reported previously for any exosome.
Messenger RNA profiling of saliva from both healthy
individuals and those with oral cancer has led to the nucleic acid
characterization of human saliva, and RNA enrichment in saliva
holds the promise of salivary biomarkers as future tools
[20,21,22,23]. Several studies suggest that exosomes may stimulate
target cells and transfer surface receptors and genetic information
[24,25,26]. In fact, exosomes were shown to transfer surface
molecules, tumor cell mRNA, and infective agents such as HIV or
prions [27,28]. In addition, Valadi and colleagues [29] demon-
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contain not only proteins but also a population of mRNA and
miRNA. Recently, exosomes derived from glioblastoma tumor
cells and blood from cancer patients were reported to promote
tumor growth and to contain mRNA and proteins useful for
diagnostic biomarkers [30]. These exosomes are attractive vesicles
for intercellular mRNA transfer because they likely provide a
protected environment to ensure stability in the presence of
extracellular RNases. Interestingly, Deregibus and colleagues
isolated microvesicles containing mRNA from endothelial precur-
sor cells and verified their transfer using GFP-tagged mRNA [24].
Additionally, Smalheiser and colleagues showed that exosomes
transfer synaptic proteins such as CAM kinase II alpha and
synaptic mRNA to the presynaptic terminal, where these factors
contribute to synaptic plasticity [31]. Although exosome mRNA
has been implicated in cell-cell signaling, the characteristic features
and transfer abilities of these vesicles are largely unknown in body
fluid such as saliva.
An intriguing aspect of the present work is the mechanism of
RNA targeting to exosomes. MVBs, the organelles from which
exosomes are derived, generated from the fusion of early
endosomes and have a well established role in the degradation
of proteins internalized from the cell surface via fusion with
lysosomes [28]. In addition to fusion with lysosomes, MVBs also
undergo exocytotic fusion with the plasma membrane and release
their ‘‘intraluminal vesicles,’’ which refers to the exosomes that are
contained within the MVBs [32]. Possibly, RNAs may initially be
internalized in the cytoplasm via early endosomes and subse-
quently incorporated into MVBs before being secreted through
the fusion of MVBs with the plasma membrane. The accumula-
tion of RNA in exosomes is a concept that has not been
investigated thoroughly. Thus, we hypothesize that saliva RNA
and proteins are secreted via the process of exosome formation.
More specifically, delivery of the exosomes to the oral cavity
occurs by fusion of the MVB outer membrane with the plasma
membrane of oral epithelial cells. Thus, saliva exosomes should
have the characteristic features of internal vesicles of MVBs [26],
and the vesicles should be small (,100 nm) and relatively uniform
in size, similar to other exosomes [33] secreted by other cells and
tissues. In addition, saliva exosomes should contain proteins like
CD63 and Alix, which is typical of MVBs and other exosomes
[29], along with genetic information. Finally, saliva exosomes
should be capable of communicating with neighboring cells such
as human oral keratinocytes and altering gene expression at the
new location.
Results
Evidence of Exosomes in Human Saliva
Exosomes were isolated from human saliva through a series of
ultracentrifugation steps with a modified version of a previously
described technique [34]. Exosomes obtained from the ultracen-
trifuge pellets were examined by EM or stained using negative
staining procedures with uranyl acetate. Electron micrographs
revealed that saliva exosomes were cup-shaped, rounded vesicles
of ,30–70 nm (Fig. 1A) similar to exosomes released in other body
fluids [13]. Notably, no visual evidence of contamination with
other membrane particles was observed in our exosome
preparations. To confirm the structures studied were exosome-
specific, the exosomes were labeled with immunogold antibody
and examined by EM (Fig. 1B). Antibody to the tetraspanin
molecule CD63 was used, as this molecule is a commonly used
marker for exosomes. The exosomes isolated from saliva appeared
as electron-dense membranous structures with an average
diameter of 30–100 nm and abundant CD63 immunoreactivity
on the surface (Fig. 1B). Furthermore, FACS analysis showed
enrichment of CD63 (trace peak) (Fig. 1C). Finally, Western blot
analysis of saliva exosomes confirmed the presence of CD63 and
Alix proteins in the ultracentrifugation pellets (Fig. 1D) and
revealed that saliva-derived vesicles are positive for CD63 and
Alix, confirming that the vesicles are indeed exosomes.
AFM Analysis of Saliva Exosomes
While EM is a standard technique for exosome characteriza-
tion, this technique may not provide a representative view of the
exosomes due to the inherently harsh sample processing
requirements. To assess the native exosome structure, we used
AFM to study the size and structure of individual isolated vesicles.
Isolated exosomes were immobilized on a mica surface (Fig. 2A
control surface with no exosomes). Exosomes appeared as isolated
vesicles with characteristic flattened donut-like structures in a 3D
topographic image (Fig. 2B). A high-resolution phase image
(Fig. 2C) of a single exosome revealed a contrast between the outer
dense walls and the inner less dense region. As the exosomes were
essentially free of cytoskeletal components, this fine structure
reflects an inherent organization of the vesicular membrane itself.
Measurements for the same exosome as shown in the topography
image revealed a width of 65 nm and a height of 2.5 nm (Fig. 2D).
Since the characteristic shape and size of exosomes is distinct from
any other structures seen on the surface, the height profile of three
individual exosomes and the size distribution of exosomes is shown
(Fig. 2E and 2F), indicating consistent morphology. Furthermore,
the size distribution shows cross-contamination of the exosomes
with small vesicles due to limitations of the separation method-
ology. Next, we have extensively used molecular recognition
spectroscopy with anti-CD63 IgG functionalized AFM tips for
imaged and investigated the highly specific and sensitive detection
of individual exosome in saliva (unpublished observation).
Presence of mRNAs in Saliva Exosomes
The presence of nucleic acids in saliva was examined to
determine a potential mechanism by which exosomes exchange
genetic information. Assessment of isolated exosomes showed that
these vesicles contained a substantial amount of RNA and not
much DNA (Fig. 3A). Treatment with RNase A and DNase
revealed the presence of mRNA in the saliva exosome preparation
(Fig. 3A lanes 3 and 4). The extracted total RNA did not contain
intact ribosomal RNA, as most of the ribosomal RNA was
degraded, heterogeneous in nature, and ,200 nucleotides in
length (Fig. 3B 1–5). These observations are consistent with
previous data which indicate no or minimal ribosomal RNA in
exosomes [29]. Microarray assessment of saliva exosomes revealed
509 core mRNA transcripts (see supplementary data Table S1)
that were common to four different microarray chip data sets (each
set was derived from pooled whole saliva samples from six healthy
subjects). A gene ontology-based analysis (www.bioinfo.vanderbilt.
edu/gotm) implicated the saliva exosome RNA in various
biological processes, including cellular and physiological processes
(Fig. 3C).
Exosome mRNA Is Stable
Enrichment of sphingomyelin, GM3, and cholesterol is a
characteristic of the so-called lipid raft domains [35], which are
otherwise known as exosomes. Such domains are usually sensitive
to solubilization with ionic detergents [36]. To determine whether
saliva exosomes display lipid raft-like properties, we determined
their solubility in the presence of 1% Triton X-100 followed by
extraction and quantification of RNA by qRT-PCR (Fig. 4). The
Exosomes in Human Saliva
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without detergent or in NP-40 (data not shown). To confirm that
the RNA is confined within the exosomes, detergent (Triton X-
100) and RNase treatment of the saliva exosomes was performed
at 37uC, and then the RNA was extracted as described in
1Materials and Methods. No differences in RNA decay were
observed between the RNase-treated and control exosomes,
whereas treatment with Triton X-100 followed by RNase
treatment destroyed the RNA molecules (Fig. 4). These observa-
tions are consistent with our previous observations on the stability
of mRNA in whole saliva [23].
Saliva Exosomes Are Biologically Functional
The transfer of mRNA from saliva exosomes to human oral
keratinocytes was demonstrated using vesicles derived from saliva
that was labeled with fluorescent lipid BODIPY-PC. The labeled
exosomes were incubated with keratinocytes and BODIPY-PC-
positive exosomes transferred to recipient cells sufficiently for
detection by fluorescence microscopy (Fig. 5, panels 1–4). The
increasing concentration of labeled exosomes incorporated into
oral keratinocytes confirmed the cell-cell communication between
these two partners. The negative control detergent lyses of
exosomes did not exhibit this interaction with oral keratinocytes.
Although exosomes obtained from saliva of healthy individuals
suggested a role in the oral microenvironment, the underlying
mechanism of salivary exosomes interaction is still unclear largely
because of limited information about saliva exosomes. Surprising-
ly, several reports have predicted cell-cell communication
functions of exosomes, but saliva exosomes have not been
examined experimentally. Because exosomes are thought to
regulate gene expression in recipient cells, we determined the
differential expression of proteins in keratinocytes after treatment
with saliva exosomes. Protein was extracted from keratinocytes
treated with either a negative control of detergent treated
exosomes and labeled with Cy3 or saliva exosomes labeled with
Cy5. Unlike conventional two-dimensional gels in which the two
samples are run in separate gels, we separated the two samples,
which were labeled with different fluorescent dyes, in a single gel,
thus eliminating gel-to-gel variation and allowing for easy
comparison of relative expression levels. After separation, several
proteins were either upregulated or downregulated (Fig. 6, red or
green, respectively). This result, in fact, is in agreement with data
indicating that mast cell-derived exosomes also up- or down-
regulate many proteins [29]. We are particularly interested in
those proteins that are differentially regulated by saliva exosomes,
because those are potentially direct targets for exosomes. Nine
protein spots with more than 2-fold expression changes in
keratinocytes treated with exosomes compared with the negative
control were chosen for closer examination (Fig. 6, indicated by
circles and numbers). Mass spectrometry analysis identified all
nine of these proteins with a good score (Table 1). Next we
investigated whether the modulated gene transcripts are present in
the saliva exosomes and could possibly be involved in the
translation. To identify these specific genes in exosomes, we
analyzed RNAs extracted from the respective saliva exosomes
using quantitative RT–PCR. The housekeeping gene b-actin was
used a reference control, and the relative quantity of mRNA
targets were measured in saliva exosomes (Fig. 7). As noted by
others, genes for annexin A1, annexin A2, moesin, keratin-6A,
eukaryotic elongation factor-2, OS-9 and interleukin-8 are present
in exosomes, suggesting that possible translation of proteins occurs
in the recipient keratinocytes [29]. In other words, altered protein
expression by recipient cells could be an ongoing translation of
these mRNAs. These data suggest that the RNA incorporated into
the exosomes may be delivered into the recipient cells and
generate a functional protein.
Figure 1. EM image of human saliva showing round-shaped exosomes. The 120,0006g pellets from saliva were used for exosomes analysis.
(A) Electron micrographs of saliva exosomes were fixed in 2% formaldehyde and contrasted using 2% uranyl acetate. The image shows small vesicles
of ,60 nm in diameter. (B) Exosomes were labeled with immunogold anti-CD63. Note the immunoreactivity of CD63 on the surface of the single
exosome. (C) Representative FACS analysis of exosomes showing expression of CD63. Open trace shows the saliva exosomes, filled trace shows saliva
exosomes incubated with latex beads and stained with anti-CD63 followed by secondary Alexa Fluor 488-conjugated antibody. (D) Western blot
analysis of saliva exosomes using an antibody against CD63 and Alix. Lane 1 is the protein extract of normal saliva, and lane 2 contains protein from
the exosome pellet obtained from ultracentrifugation.
doi:10.1371/journal.pone.0008577.g001
Exosomes in Human Saliva
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other previously identified types of MVBs. Microarray analysis
revealed the presence of 509 mRNA transcripts known to be
present in exosomes, confirming the observation that exosomes
in saliva contain RNA. In addition, experimental in vitro transfer
of saliva exosomes altered the gene expression of recipient
oral keratinocytes. Together, these studies demonstrate that
saliva exosomes are biologically active and may potentially be
a useful agent in studies aimed at disease diagnostics and
therapeutics.
Discussion
Exosomes and their genetic contents can regulate a variety of
cellular pathways through regulation of the expression of multiple
target genes in recipient cells [31]. In this regard, exosomes have
Figure 2. AFM images of saliva exosomes. Exosomes (panels B–F) were adsorbed to WGA-coated mica surfaces. (A) Topography images were
obtained with the use of the Mac mode in water (negative control—no exosomes). (B) A 3D AFM image of isolated exosomes adhering to a mica
sheet. The bar denotes 200mM. (C) A high-resolution single image of the exosome structure on the mica. (D) Graphical representation of height and
width of a single exosome. (E) Size distribution of several saliva exosomes imaged with AFM. (F) Graphical representation of the size distribution of
exosomes showing near homogeneity with respect to height and width.
doi:10.1371/journal.pone.0008577.g002
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these vesicles are secreted by many types of tumors cells. Exosomes
were previously found to be secreted in saliva [12]; although, no
physiological function was assigned. Exosomes are released into
the saliva via either ductal or acinar cells [37]. Essentially salivary
glands have been implicated in a constitutive-like secretory
pathway involved in secretion of exosomal-like vesicles. These
secretory vesicles are derived directly from the trans-Golgi or
involve elements of the endosomal-lysosomal trafficking pathway
[38]. In this study, we isolated saliva exosomes and showed that
these vesicles were, in fact, physiologically active. Consistent with
previous EM images of exosomes in body fluids [13,16,18],
ultrastructural examination of saliva exosomes revealed small
vesicles with diameters ,100 nm and a unique ‘‘cup-like’’ shape,
which are both characteristic features of exosomes. AFM also
revealed the ultrastructural features and distribution of the
exosomes.
In addition, microarray analysis indicated the presence of
mRNA inside the exosomes, and these nucleic acids were
protected against ribonucleases in saliva. Furthermore, the
exosomal RNA analysis of Valadi et al. [29] demonstrated that
virtually no ribosomal RNA was present and that most of the RNA
molecules were ,200 nucleotides in length. Moreover, saliva
exosome RNA exhibited characteristic features similar to mast
cell-derived exosomal RNA. Finally, RNA present in exosomes
was functional as modulation of gene expression was observed in
keratinocytes incubated with the exosomes. This finding was in
accord with recent reports that exosomes can transfer mRNA
horizontally to neighboring cells [24,39]. The notion that exosome
RNA is delivered to other cells provides added functional
significance to salivary exosomes.
Figure 3. Exosomes contain mRNA species. (A) RNA from saliva
exosomes was detected using an Agilent bioanalyser. Lane 1, RNA
ladder showing sizes of the nucleotides on the left. Representative lanes
(2–5) showing sizes of the mRNA species identified using an Agilent
bioanalyser electrophorogram. The saliva exosomal RNA contains no
ribosomal RNA as seen by the small heterogeneous RNA fragments
(,200 nucleotides). (B) Bioanalyzer graphical data shows the size
distribution of total RNA extracted from saliva exosomes (1) profile of
RNA standard (2) total RNA extracted from saliva exosomes without any
treatments (3) total RNA treated with DNase (4) total RNA treated with
RNase A and (5) total RNA treated with both DNase and RNase A. (C)
Figure 4. Saliva exosomes treated with Triton X-100 and RNase
had different RNA content compared to control, indicating
that RNA is protected inside the exosomes. Higher Ct values
represent lower RNA content. Error bars denote SEM (n=3).
doi:10.1371/journal.pone.0008577.g004
The biological process ontology of the 509 core mRNA species
identified in the saliva exosomes.
doi:10.1371/journal.pone.0008577.g003
Exosomes in Human Saliva
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and mRNA molecules, which originate from endocytic release.
Because exosomes are formed as MVBs, these particles likely
contain factors required for MVB formation and protein sorting.
Analysis of exosomes derived from human mast cells, dendritic
cells, and epithelial cells as well as other cell types revealed the
presence of common and cell type-specific proteins and mRNA.
For example, the aquaporin family of proteins was especially
enriched in exosomes derived from body fluids such as urine and
amniotic fluid [13,14]. Human saliva and saliva exosomal proteins
have been identified and cataloged in detail [11,40,41] including
aquaporins, cytoskeleton proteins, and membrane proteins, which
have also been found in exosomes from other cell types.
Importantly, sorting of disease-specific proteins into exosomes is
quite useful for diagnostic applications [9]. The molecular factors
and mechanisms behind this cell-specific sorting process in
exosomes are still unknown, and such an analysis may help their
translational utility.
Proteomics analysis of saliva ductal fluids revealed 1,166
proteins, including various membrane-bound proteins [40].
Interestingly, the aquaporin protein family, which is involved in
water flow through membranes, was identified in saliva. Aqua-
porins have been identified on both the apical and basolateral
membranes of secretory acinar cells of salivary glands [37].
Surprisingly, AQP1 and AQP2 proteins identified in urine
exosomes via secretion through renal ductal cells were implicated
in pathophysiological processes in urinary epithelial cells [13].
Additionally, decreases in aquaporin expression are linked to
various kidney and pancreas diseases, while reduced aquaporin
expression in salivary glands is linked to Sjo ¨gren’s syndrome [42].
Furthermore, the annexin family of proteins bind to intracellular
membranes and is involved in intracellular membrane fusion [43].
Association of annexins with exosomes may result from the
presence of phosphatidylserine in these vesicles [44]. Interestingly,
Annexins and Alix proteins are reportedly present in saliva
exosomes [11]. Differential expression of annexin A1, annexin A2,
moesin, and OS-9 proteins indicated the influence of saliva
exosomes in oral keratinocytes. Interestingly, presence of annexin
A1 mRNA in saliva exosomes may translate protein in the
recipient cell gene expression. In addition, moesin, which is an
actin-binding protein of the ERM family in exosomes, has been
demonstrated to play a role in de novo actin assembly on
phagosomal membranes [45]. Further, moesin has been reported
to be present in B cell-derived exosomes [46] and breast milk [18].
Clearly, exosome-like microvesicles are present in body fluids
such as saliva, blood, amniotic fluid, and pleural effusions under
both healthy and disease conditions; however, the origin of these
exosomes and their intended destination for stimulation of distal
cells remains unclear. Here, we demonstrated that saliva exosomes
can be taken up by oral keratinocytes. Interestingly, our
observation establishes another dimension of cell-cell communi-
cation of body fluid exosomes. Notably, keratinocytes are able to
secrete exosomes and externalize stratifin protein, which is a
potent stimulant of metalloproteinases in fibroblasts [47]. Argu-
ably, both keratinocytes and saliva exosomes engage in cell-cell
communication, and the possibility exists that part of the saliva
Figure 5. Oral keratinocytes (5610
7 cells/well) were incubated for 24 hr in KSFM media with fluorescently labeled exosomes and
examined under fluorescence microscopy. The lysed lanes serve as a negative control. Magnification was 106, and the smaller boxed panels
represent magnification of 406. Note the fluorescence intensity increases with increasing amounts of exosomes (32 and 64 ml, respectively).
doi:10.1371/journal.pone.0008577.g005
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interactions are involved in a novel mechanism of cell-cell
communication is an intriguing, yet unanswered, question. Our
studies do not directly identify the functional consequence of
mRNA release via exosomes; however, saliva exosomes carrying
mRNA transcripts of these specific altered proteins suggest that
these RNAs could possibly be translated into proteins at their new
location. Also, recent studies suggest an important role for
exosomes in the modulation of host gene expression levels.
Interestingly, exosomes purified from mast cells [29] and neuronal
cells [24] are enriched in mRNA molecules that stimulate and
alter gene expression of recipient cells. These data have led to the
suggestion that secreted exosomes expressing relevant mRNAs
may play a role in the generation of new genes and modulate gene
expression of recipient cells. Indeed, annexin and moesin are
overexpressed in keratinocytes following incubation with saliva
exosomes. We cannot rule out the presence of lipids and proteins
in saliva exosomes that also can trigger gene expression at their
new recipient cells. We have observed several ceramide lipid
species in saliva exosomes that could potentially have impact on
oral keratinocytes (unpublished observation). Finally, the source of
these exosomes in saliva, however, is probably heterogeneous, and
formal demonstration that salivary glands secrete exosomes in vivo
awaits further analyses.
In summary, saliva exosomes may regulate cell-cell environment
by altering their gene expression. This study extends our
knowledge about human saliva exosomes. In addition to genetic
regulation, as mentioned above, saliva exosomes are involved in
protecting nucleic acids against nucleases in the oral cavity. Thus,
saliva exosomes, like other types of exosomes, clearly have multiple
Figure 6. Identification of differentially expressed proteins from oral keratinocytes treated with saliva exosomes by 2-DIGE. Proteins
from cells treated with the negative control were labeled with Cy3 (green) and proteins from cells treated with saliva exosomes were labeled with Cy5
(red). Isoelectric focusing was carried out at pH 3–10, and 2D separation was performed with 8–14% gradient SDS-PAGE. The negative control
represents protein profiles of keratinocytes treated with detergent lysed exosomes. The bottom gel image reveals differentially expressed proteins in
the control and treated samples after merging. Protein spots shown in red are presumably due to upregulation by exosome treatment, and those in
green are due to downregulation by exosome treatment. Such spots are circled and numbered.
doi:10.1371/journal.pone.0008577.g006
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identified in the near future using the same proteomic approach
for various systemic diseases. These discoveries will allow us to
better understand the molecular basis of oral diseases. The studies
of Valadi [29], Skog [30], and Ratajczak [39] as well as the present
study open up a new research perspective on the use of exosomal
transfer of mRNA to target another cell type. In particular, the
results of the present study indicate that exosomes derived from
human saliva activate or modulate gene expression in oral
keratinocytes.
Methods
In this study, we employed several molecular approaches
including EM and AFM to characterize saliva exosomes. Next, we
determined whether RNAs present in saliva exosomes are
protected and whether this genetic information is shared between
cells.
Participants
Saliva samples were obtained from healthy volunteers from the
Division of Otolaryngology, Head, and Neck Surgery, at the
Medical Center, University of California, Los Angeles (UCLA),
CA in accordance with a protocol approved by the UCLA
Institutional Review Board. All participants gave written informed
consent, and the ethics committee of UCLA approved the study.
The mean age of the volunteers was 31 years (range 26–43 years).
The volunteers had no history of malignancy, immune deficien-
cies, autoimmune disorders, hepatitis, or HIV infection.
Purification of Exosomes
Exosomes were prepared as described [34] with slight
modifications. Briefly, 50 ml of saliva was mixed with an equal
volume of PBS and centrifuged at 26006g for 15 min to remove
cells. The supernatants were then sequentially centrifuged at
12,0006g for 20 min and 120,0006g for 3 hours. The final pellet
was resuspended in PBS and then used either for immunoblotting
or for EM. Notably, saliva is highly viscous in nature and it is
very difficult to apply filtration procedures with specific
membrane filters (0.2 mM or 0.45 mM size) before it undergoes
ultracentrifugation.
Immunoelectron Microscopy
The isolated exosomes were loaded onto carbon-coated grids,
fixed in 2% paraformaldehyde, washed, and then immunolabeled
with anti-CD63 antibody (Santa Cruz Biotechnology, Santa Cruz,
CA) followed by a 10 nm gold-labeled secondary antibody (Sigma
Aldrich, St. Louis, MO). The exosomes were post-fixed in 2.5%
glutaraldehyde, washed three times, contrasted with 2% uranyl
acetate, and then examined with a JEOL 100CX transmission
electron microscope (JEOL USA, Inc. Peabody, MA).
Atomic Force Microscopy
For AFM imaging of isolated exosomes purified samples were
diluted 1:100 in deionized water and adsorbed to freshly cleaved
mica sheets for 10 min. The sheets were rinsed thoroughly with
deionized water to remove unbound exosomes and dried under a
Figure 7. Protein expression modulated in saliva exosomes.
ANXA1, ANXA2, moesin, keratin-6A, EEF2, OS-9, and IL-8 RNA expression
was normalized using a factor calculated from b-Actin gene expression.
doi:10.1371/journal.pone.0008577.g007
Table 1. Proteins expressed differentially in oral keratinocytes.
Spot
number Protein name Accession No.
Protein
MW
Protein
Abundance
Peptide
count Functional Annonation
1 OS-9 gi|48145699 69189.4 Increased 9 Protein binding
6 Eukaryotic translation elongation factor 2 gi|4503483 95277 Increased 29 GTP binding, translation elongation
activity
12 Keratin 6A gi|15559584 59981.3 Decreased 8 Structural molecule activity
22 Serine (or cysteine) proteinase inhibitor, clade B
(ovalbumin), member 2
gi|4505595 46566.1 Increased 22 Serine-type endopeptidase activity
24 Annexin A1 gi|54696696 38690 Increased 16 Calcium/phospholipid-binding
protein, Involved in exocytosis
25 Annexin A2 gi|30583703 38579.8 Decreased 18 Calcium binding protein, involved in
exocytosis
27 Human Muscle L-Lactate Dehydrogenase M Chain gi|13786856 36534.3 Increased 17 dehydrogenase activity, protein
binding
10 Moesin gi|5419633 67777.8 Increased 31 Cytoskeletal protein binding
doi:10.1371/journal.pone.0008577.t001
Exosomes in Human Saliva
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Santa Barbara, CA) was used for tapping mode AFM imaging
using silicon probes with spring constant k=305 KHz (OTESPA,
Veeco). Topographic height and phase images were recorded
simultaneously at 5126512 pixels at a scan rate of 0.4 Hz. The
height of the exosomes was obtained from a line profile of height
images (Nanoscope software). Image processing was performed
using the WxSM free software (Nanotec, Spain).
Immunoblotting and Flow Cytometry
Exosomal proteins were extracted and separated on a
polyacrylamide gel before transfer to a nitrocellulose membrane.
The blotting membrane was blocked and incubated with CD63
antibody followed by incubation with horseradish peroxidase-
coupled secondary antibody. The proteins were detected using
enhanced chemiluminescence. For FACS analysis, saliva exosomes
were absorbed onto 4-mm aldehyde-sulfate latex beads (Interfacial
Dynamics, OR) and incubated with CD63 antibody and/or Alix
(Santa Cruz Biotechnology, Santa Cruz, CA) followed by an
incubation with a secondary antibody (Molecular Probes, Invitro-
gen, CA). The exosomes were then washed and analyzed on a
FACSscan (BD Biosciences, San Diego, CA).
RNA Isolation and Amplification
RNA was isolated from 300 mg of saliva exosomes with the
RNeasy Mini Kit (Qiagen, Valencia, CA), according to the
manufacturer’s instructions. All samples were treated with TURBO
DNA-free (Ambion, Austin, TX) to remove trace amounts of
genomic DNA. A 2-round amplification was performed with the
RiboAmp RNA Amplification Kit (Molecular Devices, Sunnyvale,
CA) according to the manufacturer’s instructions.
RNA Detection and Analysis
Detection of RNA was achieved using the Agilent 2100
Bioanalyser (http://www.chem.agilent.com). Triton X-100 (Sig-
ma) was added at a final concentration of 1%, and exosomes were
incubated at room temperature for up to 30 min with and without
RNase A and DNase at a final concentration of 100 units/ml.
After RNA isolation, additional water and Triton X-100 were
added to the respective samples to balance the chemical
composition.
Microarray Analysis
The microarray experiments were performed by the UCLA
microarray core facility according to the Affimetrix microarray
analysis protocols. Briefly, single-stranded cDNA was generated
from the amplified cRNA with the WT cDNA Synthesis Kit
(Affymetrix, Santa Clara, CA) and then fragmented and labeled
with the WT Terminal Labeling Kit (Affymetrix). Samples were
hybridized with GeneChip HGU-133 plus 2 Arrays (Affymetrix)
and scanned at the UCLA Microarray Core Facility. Raw data
were processed with the Quantile normalization (part of GCRMA
package). A detection p-value was obtained for each probe set. Any
probe set with p,0.04 was assigned as ‘‘present’’, indicating that
the matching gene transcript was reliably detected. The total
number of present probe sets on each array was obtained, and the
percentage (P%) of present genes was calculated. The program R-
package was used for gene profiling analysis, and the gene
ontology software was used for the biological process analysis.
RT-PCR Preamplification
Multiplex RTPCR preamplifications were performed in 10-mL
reaction volumes with a pool of outer primers at 300 nmol/L each
and the SuperScript III Platinum One-Step qRT-PCR System
(Invitrogen). Reactions were prepared on ice, loaded into a
preheated thermocycler, and performed as follows: 1 min at 60uC,
15 min at 50uC, 2 min at 95uC, and 15 cycles of 15 s at 95uC, 30 s
at 50uC, 10 s at 60uC, and 10 s at 72uC. These steps were followed
with a final extension of 5 min at 72uC and cooling to 4uC.
Immediately after the RT-PCR, we treated 5 mL of the reaction
with 2 mL of ExoSAP-IT (USB Corporation) for 15 min at 37uC
to remove excess primers and deoxynucleoside triphosphates and
then heated the mixtures to 80uC for 15 min to inactivate the
enzyme mix. The preamplification products were then diluted 40-
fold with water to 200 mL to enable qPCR analysis of all targets.
Quantitative PCR
Each transcript was quantified from 2 mL aliquots of pre-
amplified samples via a singleplex qPCR in an SDS 7500 Fast
instrument (Applied Biosystems, Foster City, CA) with a 10-mL
reaction volume containing 300 nmol/L of each of the inner
primers and the SYBR Green Power Master Mix (Applied
Biosystems). After 10 min of polymerase activation at 95uC, we
carried out 40 cycles of 15 s at 95uC and 60 s at 60uC and then
performed a melting curve analysis. Table S2 shows the primers
sets used for this study (supplementary methods).
In Vitro Labeling of Exosomes
The in vitro labeling of exosomes was performed as described
[48] with slight modification. Briefly, purified saliva exosomes
were incubated with 10 mM of BODIPY-PC in PBS for 30 min at
37uC in the dark. Excess fluorescent lipids were removed by
ultracentrifugation at 120,0006g for 1.5 hours at 4uC. Labeled
exosomes were then resuspended with PBS and then used for in
vitro transfer experiments.
Cells and In Vitro Transfer Experiments
Immortalized human oral keratinocytes (OKF6tert1) were
cultured and harvested under log phase conditions as described
previously [49]. For in vitro transfer experiments, the labeled saliva
exosomes were added to oral keratinocytes (2610
7) at a final
concentration of 2 mg/ml. At 0 hr and 24 hr, cells were harvested
and washed three times. Total cellular proteins were extracted and
separated by 2D electrophoresis. A sample with 1% Triton X-100
of lysed exosomes was treated similarly and used as a negative
control.
Accession Numbers
Details about the microarray data deposition can be found at
http://www.ncbi.nlm.nih.gov/geo (the GEO accession number is:
GSE13494). All the data obtained from Microarray are in
accordance with MIAME compliant, as detailed on the website
www.mged.org/workgroups/MIAME.miame.html.
Proteomic Analysis of Exosomes Transfer Experiment
Samples
Oral keratinocytes that were harvested after incubation with
exosomes were sent directly for 2-DIGE and mass spectrometry
analysis by Applied Biomics (Hayward, CA) Briefly, total protein
was extracted, labeled with Cy3 and Cy5 dyes (GE Healthcare,
Piscataway, NJ), and subjected to isoelectric focusing (pH 3–10)
and sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE). Gel scanning was carried out immediately after
SDS-PAGE using Typhoon TRIO (GE Healthcare, Piscataway,
NJ). Scanned images were analyzed by Image Quant software
(version 5.0, GE Healthcare) and subjected to in-gel analysis and
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Healthcare) with a detection limit of 0.2 ng of protein per spot.
The ratio change for differentially expressed protein spots was
obtained from the in-gel DeCyder analysis. Protein spots of
interest that were consistently differentially expressed in exosomes-
versus vehicle-treated samples across a minimum of two SDS gels
were picked up by Ettan Spot Picker (GE Healthcare, Piscataway,
NJ) and subjected to in-gel trypsin digestion, peptide extraction,
and desalting prior to MALDI-TOF/MS-MS (ABI 4700, Applied
Biosystems, CA). Peptide fingerprints and partial amino acid
sequence information were used for protein identification in the
nrNCBI nonredundant National Center for Biotechnology)
databases. Searches were performed without constraining protein
molecular weight (MW) or isoelectric point (IP), with variable
carbamidomethylation of cysteine and oxidation of methionine
residues, and with one missed cleavage allowed in the search
parameters. Candidates with protein and ion scores greater than
95% were considered significant.
Statistical Analysis
Data are expressed as means6SEM and P values ,0.01 were
considered statistically significant according to the Student’s t test.
Supporting Information
Table S1 Supplementary data
Found at: doi:10.1371/journal.pone.0008577.s001 (0.08 MB
XLS)
Table S2 Supplementary methods
Found at: doi:10.1371/journal.pone.0008577.s002 (0.03 MB
DOC)
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